Filtered By:
Source: Atherosclerosis
Countries: Jordan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Clinical profiles and one-year outcome in middle eastern patients with atrial fibrillation and major bleeding events. The Jordan atrial fibrillation study
Background and Aims: Oral anticoagulant agents (OACs) reduce the risk of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) but may increase the risk of major bleeding (MB) events. There is a scarcity of studies that address the incidence, predictors, and outcomes of bleeding events in AF patients in the Middle East. This contemporary multicenter study sought to evaluate in detail the bleeding events and predictors of these events
Source: Atherosclerosis - August 1, 2023 Category: Cardiology Authors: A. Hammoudeh, Y. Khader, Y. Badaineh, R. Tabbalat, S. Rawashdeh, M. Jammal, S. Abrumman, I. Alhaddad Source Type: research
